Daniel A Haber Selected Research

Rhabdomyosarcoma

1/2019	Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.
5/2009	Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel A Haber Research Topics

Disease

108	Neoplasms (Cancer) 04/2024 - 03/2002
28	Circulating Neoplastic Cells 03/2024 - 07/2008
24	Lung Neoplasms (Lung Cancer) 09/2023 - 05/2004
22	Breast Neoplasms (Breast Cancer) 08/2023 - 09/2003
17	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2007
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2004
11	Melanoma (Melanoma, Malignant) 04/2024 - 06/2008
11	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 03/2010
11	Carcinogenesis 03/2023 - 03/2003
7	Adenocarcinoma 12/2019 - 04/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 07/2006
6	Oncogene Addiction 02/2015 - 02/2006
5	Disease Progression 01/2023 - 08/2007
5	Ewing Sarcoma (Sarcoma, Ewing) 11/2014 - 03/2002
5	Wilms Tumor (Wilm's Tumor) 06/2010 - 03/2002
3	Desmoplastic Small Round Cell Tumor 06/2008 - 12/2002
2	Brain Neoplasms (Brain Tumor) 12/2020 - 11/2014
2	Rhabdomyosarcoma 01/2019 - 05/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 05/2009
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2012 - 08/2004
2	Genetic Translocation (Chromosomal Translocation) 06/2008 - 05/2008
2	Warts (Wart) 04/2008 - 08/2002
2	Shock 03/2007 - 07/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2007 - 11/2005
2	Ovarian Neoplasms (Ovarian Cancer) 07/2005 - 03/2003
1	Hypoxia (Hypoxemia) 12/2020
1	Starvation 10/2020

Drug/Important Bio-Agent (IBA)

27	RNA (Ribonucleic Acid)IBA 03/2024 - 03/2010
25	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2004
23	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2002
21	Phosphotransferases (Kinase)IBA 01/2022 - 08/2004
15	Tyrosine Kinase InhibitorsIBA 03/2016 - 05/2004
14	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2007
12	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2007
12	Gefitinib (Iressa)FDA Link 05/2008 - 05/2004
9	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015 - 05/2005
8	Transcription Factors (Transcription Factor)IBA 04/2024 - 03/2002
8	LigandsIBA 04/2024 - 03/2002
6	Estrogen ReceptorsIBA 08/2023 - 06/2004
5	EpitopesIBA 10/2022 - 04/2013
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 03/2012
4	Hormones (Hormone)IBA 08/2023 - 06/2004
4	ChromatinIBA 01/2023 - 06/2010
4	Small Interfering RNA (siRNA)IBA 12/2020 - 09/2003
4	olaparibIBA 01/2020 - 11/2014
4	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 11/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2010 - 05/2004
3	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2018
3	Epithelial Cell Adhesion MoleculeIBA 01/2022 - 04/2012
3	AndrogensIBA 01/2018 - 11/2012
3	Circulating Tumor DNAIBA 03/2016 - 06/2014
3	MicroRNAs (MicroRNA)IBA 09/2015 - 06/2006
3	Tamoxifen FDA LinkGeneric 05/2014 - 06/2004
3	Protein Kinases (Protein Kinase)IBA 07/2013 - 08/2002
3	Protein Isoforms (Isoforms)IBA 07/2010 - 11/2004
3	AgarIBA 08/2007 - 12/2002
2	Cysteine (L-Cysteine)FDA Link 04/2024 - 10/2023
2	Cadherins (E-Cadherin)IBA 10/2022 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 10/2019 - 01/2019
2	neratinibIBA 01/2019 - 05/2005
2	Mitogen-Activated Protein KinasesIBA 01/2019 - 07/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 07/2014 - 07/2013
2	MitogensIBA 07/2013 - 06/2008
2	Oncogene Proteins (Oncogene Protein)IBA 11/2012 - 07/2006
2	Histones (Histone)IBA 02/2012 - 06/2006
2	CrizotinibIBA 12/2011 - 10/2010
2	Anaplastic Lymphoma KinaseIBA 10/2010 - 05/2008
2	Long-Acting Thyroid Stimulator (LATS)IBA 04/2008 - 08/2002
2	Growth Factor ReceptorsIBA 04/2006 - 02/2006
1	Radium-223IBA 02/2024
1	CarcinogensIBA 09/2023
1	Poly GIBA 09/2023
1	GuanineIBA 09/2023
1	elacestrantIBA 08/2023
1	Fulvestrant (Faslodex)FDA Link 08/2023
1	palbociclibIBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	abemaciclibIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	osteoblast cadherinIBA 10/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Aromatase InhibitorsIBA 07/2021
1	AntioxidantsIBA 01/2021
1	IronIBA 01/2021
1	ferrostatin-1IBA 01/2021
1	Transferrin (beta 2 Transferrin)IBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	AntigensIBA 01/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020

Therapy/Procedure

41	Therapeutics 08/2023 - 02/2006
6	Drug Therapy (Chemotherapy) 10/2020 - 02/2007
5	Lab-On-A-Chip Devices 05/2016 - 07/2008
4	Castration 02/2024 - 11/2012
2	Aftercare (After-Treatment) 08/2015 - 07/2013
1	Injections 12/2020
1	Surgical Instruments (Clip) 01/2020